Next Article in Journal
Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients
Next Article in Special Issue
Safety and Efficacy of 177Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing 223Radium-Dichloride
Previous Article in Journal
Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
Previous Article in Special Issue
Salvage Radioligand Therapy with Repeated Cycles of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement
 
 

Order Article Reprints

Journal: Cancers, 2021
Volume: 13
Number: 4193

Article: Outcome of 177Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer
Authors: by Nicolai Mader, Daniel Groener, Nikolaos Tselis, Séverine Banek, James Nagarajah, Frank Grünwald and Amir Sabet
Link: https://www.mdpi.com/2072-6694/13/16/4193

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop